Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · CME (CME)

CME Group names CFO Lynne Fitzpatrick CEO, Terry Duffy to become Executive Chairman

Neutral Impact 4 of 5 leadership Written later

CME Group said Chairman and CEO Terry Duffy will become Executive Chairman, and President and CFO Lynne Fitzpatrick will succeed him as CEO. The change takes effect on the later of March 1, 2027 and the date the company files its 2026 Form 10-K. The company will also search for a new CFO to succeed Fitzpatrick.

Key points

  • Transition effective on the later of March 1, 2027 and the filing date of the 2026 Form 10-K; Board approved it June 16, 2026
  • Duffy serves as Executive Chairman from the Transition Date through December 31, 2027
  • Fitzpatrick's agreement sets a $1.2 million annual base salary, a bonus opportunity of 200% of salary and a long-term incentive opportunity of 700% of salary
  • Fitzpatrick's severance includes a lump sum of two times annual base salary and 18 months of Company-paid healthcare coverage

The filing

CompanyCME (CME)
Form8-K, current report
Filed with the SECJun 17, 2026, 8:35 AM ET
Accession number0001193125-26-273442

Items reported: 5.02 Director / Officer Change7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:21 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on June 17, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.